IDEXX Laboratories Inc (IDXX)
493.87
+14.30
(+2.98%)
USD |
NASDAQ |
Apr 23, 16:00
494.15
+0.28
(+0.06%)
Pre-Market: 09:12
IDEXX Laboratories Revenue (TTM): 3.661B for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.661B |
| September 30, 2023 | 3.588B |
| June 30, 2023 | 3.514B |
| March 31, 2023 | 3.431B |
| December 31, 2022 | 3.367B |
| September 30, 2022 | 3.340B |
| June 30, 2022 | 3.309B |
| March 31, 2022 | 3.274B |
| December 31, 2021 | 3.215B |
| September 30, 2021 | 3.135B |
| June 30, 2021 | 3.047B |
| March 31, 2021 | 2.858B |
| December 31, 2020 | 2.707B |
| September 30, 2020 | 2.591B |
| June 30, 2020 | 2.475B |
| March 31, 2020 | 2.457B |
| December 31, 2019 | 2.407B |
| September 30, 2019 | 2.351B |
| June 30, 2019 | 2.291B |
| March 31, 2019 | 2.252B |
| December 31, 2018 | 2.213B |
| September 30, 2018 | 2.170B |
| June 30, 2018 | 2.117B |
| March 31, 2018 | 2.045B |
| December 31, 2017 | 1.969B |
| Date | Value |
|---|---|
| September 30, 2017 | 1.906B |
| June 30, 2017 | 1.862B |
| March 31, 2017 | 1.820B |
| December 31, 2016 | 1.775B |
| September 30, 2016 | 1.732B |
| June 30, 2016 | 1.690B |
| March 31, 2016 | 1.637B |
| December 31, 2015 | 1.602B |
| September 30, 2015 | 1.554B |
| June 30, 2015 | 1.531B |
| March 31, 2015 | 1.508B |
| December 31, 2014 | 1.486B |
| September 30, 2014 | 1.488B |
| June 30, 2014 | 1.443B |
| March 31, 2014 | 1.405B |
| December 31, 2013 | 1.377B |
| September 30, 2013 | 1.343B |
| June 30, 2013 | 1.320B |
| March 31, 2013 | 1.303B |
| December 31, 2012 | 1.293B |
| September 30, 2012 | 1.281B |
| June 30, 2012 | 1.266B |
| March 31, 2012 | 1.249B |
| December 31, 2011 | 1.219B |
| September 30, 2011 | 1.195B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
2.291B
Minimum
Jun 2019
3.661B
Maximum
Dec 2023
3.001B
Average
3.135B
Median
Sep 2021
Revenue (TTM) Benchmarks
| Stryker Corp | 20.50B |
| Haemonetics Corp | 1.270B |
| Align Technology Inc | 3.862B |
| Edwards Lifesciences Corp | 6.005B |
| ACADIA Pharmaceuticals Inc | 726.44M |